Medical Transcription Billing, Corp. (NasdaqCM:MTBC) announces a share repurchase program. Under the program, the company will repurchase up to $1 million worth of its common stock.

The repurchase program allows the company to repurchase shares in open-market purchases in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The company will finance stock repurchases with existing cash balances. Repurchases will depend upon a variety of factors, such as price, market conditions, volume limitations on purchases and other regulatory requirements, and other corporate considerations, as determined by the company.

The repurchase program reflects strong confidence in company's growth prospects, strategy and ability to generate long-term shareholder returns. The repurchase program does not require the purchase of any minimum number of shares and may be modified, suspended or discontinued at any time. The plan expires on January 27, 2017.